Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.119 EUR | -0.50% | -2.14% | -27.88% |
2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Sales 2021 | 4.06M 4.32M | Sales 2022 | 1.44M 1.54M | Capitalization | 15.64M 16.65M |
---|---|---|---|---|---|
Net income 2021 | -5M -5.32M | Net income 2022 | -19M -20.23M | EV / Sales 2021 | 7.53 x |
Net cash position 2021 | 7.95M 8.47M | Net cash position 2022 | 4.45M 4.74M | EV / Sales 2022 | 7.75 x |
P/E ratio 2021 |
-6
x | P/E ratio 2022 |
-0.76
x | Employees | 39 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 73.93% |
1 day | -0.50% | ||
1 week | -2.14% | ||
Current month | +10.19% | ||
1 month | +21.43% | ||
3 months | -9.85% | ||
6 months | -47.35% | ||
Current year | -27.88% |
Managers | Title | Age | Since |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 21-05-31 |
Ashish Gulati
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Miara
BRD | Director/Board Member | - | 20-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 21-10-13 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 60 | 11-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.119 | -0.50% | 40 025 |
24-04-18 | 0.1196 | +1.18% | 51,948 |
24-04-17 | 0.1182 | 0.00% | 14,060 |
24-04-16 | 0.1182 | -2.31% | 29,393 |
24-04-15 | 0.121 | -0.49% | 87,629 |
Real-time Euronext Paris, April 19, 2024 at 05:04 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.88% | 19.65M | |
+27.97% | 672B | |
+23.52% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+1.79% | 211B | |
-0.68% | 203B | |
-10.43% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- ALVIO Stock